{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T12:07:20Z","timestamp":1772107640430,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.reuma.2012.06.014","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T17:35:32Z","timestamp":1383932132000},"page":"94-100","source":"Crossref","is-referenced-by-count":25,"title":["Uso de recursos e impacto econ\u00f3mico de los pacientes con gota: estudio multic\u00e9ntrico de \u00e1mbito poblacional"],"prefix":"10.1016","volume":"9","author":[{"given":"Antoni","family":"Sicras-Mainar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Navarro-Artieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Ib\u00e1\u00f1ez-Nolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2012.06.014_bib0005","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/SMJ.0b013e3181a8cab9","article-title":"Prevalence of gout and hyperuricemia in Taiwan: a hospital-based, cross-sectional study","volume":"102","author":"Lai","year":"2009","journal-title":"South Med J"},{"key":"10.1016\/j.reuma.2012.06.014_bib0010","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nrrheum.2010.78","article-title":"Epidemiology: gout-bad for the heart as well as the joint","volume":"6","author":"So","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.reuma.2012.06.014_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3810\/pgm.2011.11.2511","article-title":"European League Against Rheumatism. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia","volume":"123","author":"Hamburger","year":"2011","journal-title":"Postgrad Med"},{"key":"10.1016\/j.reuma.2012.06.014_bib0020","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/art.1780200320","article-title":"Preliminary criteria for the classification of the acute arthritis of primary gout","volume":"20","author":"Wallace","year":"1977","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2012.06.014_bib0025","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2006.055269","article-title":"EULAR Evidence based recommendations for gout Part II. Management. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)","volume":"65","author":"Zhang","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2012.06.014_bib0030","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/ard.2009.123687","article-title":"Limited validity of the American College of Rheumatology criteria for classifying patients with gout in primary care","volume":"69","author":"Janssens","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reuma.2012.06.014_bib0035","first-page":"S639","article-title":"Diagnosis of gout in the rheumatology, hospital-based setting lies far from that recommended: results from the GEMA (Gout Evaluation of Management) Study","volume":"56","author":"Perez-Ruiz","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2012.06.014_bib0040","first-page":"2452","article-title":"Outcome measures for acute and chronic gout","volume":"32","author":"Schumacher","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2012.06.014_bib0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.numecd.2005.11.012","article-title":"Endothelial dysfunction and oxidative stress in arterial hypertension","volume":"16","author":"Ferroni","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.reuma.2012.06.014_bib0050","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11926-010-0084-3","article-title":"Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?","volume":"12","author":"Shah","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.reuma.2012.06.014_bib0055","first-page":"1882","article-title":"Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome","volume":"34","author":"Hjortnaes","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2012.06.014_bib0060","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/art.22466","article-title":"Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey","volume":"57","author":"Choi","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reuma.2012.06.014_bib0065","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.amjhyper.2006.02.014","article-title":"Serum uric acid is a determinant of metabolic syndrome in a population-based study","volume":"19","author":"Onat","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.reuma.2012.06.014_bib0070","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel III final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.reuma.2012.06.014_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RHU.0b013e3181951e87","article-title":"Health care costs in gout: what are these emerging data telling us?","volume":"15","author":"Singh","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.reuma.2012.06.014_bib0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.18553\/jmcp.2008.14.2.164","article-title":"Disease-related and all-cause health care costs of elderly patients with gout","volume":"14","author":"Wu","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.reuma.2012.06.014_bib0085","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0149-2918(03)80158-3","article-title":"A literature review of the epidemiology and treatment of acute gout","volume":"25","author":"Kim","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.reuma.2012.06.014_bib0090","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3899\/jrheum.080487","article-title":"Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter?","volume":"36","author":"Wu","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2012.06.014_bib0095","first-page":"225","article-title":"El costo de las principales enfermedades reum\u00e1ticas inflamatorias desde la perspectiva del paciente en M\u00e9xico","volume":"144","author":"Mould-Quevedo","year":"2008","journal-title":"Gac M\u00e9d M\u00e9x"},{"key":"10.1016\/j.reuma.2012.06.014_bib0100","first-page":"908","article-title":"A cost effectiveness analysis of urate lowering drugs in nontophaceous recurrent gouty arthritis","volume":"22","author":"Ferraz","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reuma.2012.06.014_bib0105","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1185\/030079906X112606","article-title":"The economic burden of gout on an employed population","volume":"22","author":"Brook","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.reuma.2012.06.014_bib0110","series-title":"The International Classification of Primary Care in the European Community. With a multi-language layer","year":"1993"},{"key":"10.1016\/j.reuma.2012.06.014_bib0115","unstructured":"Ministerio de Sanidad, Servicios Sociales e Igualdad. Portal estad\u00edstico del SNS 2010. Clasificaci\u00f3n Internacional de Enfermedades, novena revisi\u00f3n, Modificaci\u00f3n Cl\u00ednica (CIE-9-MC) [accedido diciembre 2011]. Disponible en: http:\/\/www.msc.es\/estadEstudios\/estadisticas\/normalizacion\/clasifEnferm\/home.htm"},{"key":"10.1016\/j.reuma.2012.06.014_bib0125","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.reuma.2012.06.014_bib0130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1097\/00005650-199105000-00006","article-title":"Development and application of a population-oriented measure of ambulatory care case-mix","volume":"29","author":"Weiner","year":"1991","journal-title":"Med Care"},{"key":"10.1016\/j.reuma.2012.06.014_bib0160","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1161\/01.CIR.0000080897.52664.94","article-title":"Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study","volume":"108","author":"Sattar","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.reuma.2012.06.014_bib0135","unstructured":"Instituto Nacional de Estad\u00edstica 2010. Encuesta de costes laborales del a\u00f1o 2010 [accedido diciembre 2011]. Disponible en: http:\/\/www.ine.es\/infoine"},{"key":"10.1016\/j.reuma.2012.06.014_bib0140","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1136\/bmj.320.7243.1197","article-title":"How should cost data in pragmatic randomised trials be analysed?","volume":"320","author":"Thompson","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.reuma.2012.06.014_bib0145","first-page":"85","article-title":"S\u00edndrome metab\u00f3lico, hiperuricemia y gota","volume":"7","author":"Fraile","year":"2009","journal-title":"Rev Esp Obes"},{"key":"10.1016\/j.reuma.2012.06.014_bib0150","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1185\/03007990903017966","article-title":"Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis","volume":"25","author":"Halpern","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.reuma.2012.06.014_bib0155","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1185\/030079905X38240","article-title":"The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database","volume":"21","author":"Joish","year":"2005","journal-title":"Curr Med Res Opin"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X1200215X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X1200215X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,11]],"date-time":"2022-03-11T22:37:24Z","timestamp":1647038244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X1200215X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1699258X1200215X"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2012.06.014","relation":{},"ISSN":["1699-258X"],"issn-type":[{"value":"1699-258X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}